Alexander Fletcher-Sandersjöö1, Björn Frenckner2, Mikael Broman3. 1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden. Electronic address: alexander.sandersjoo@gmail.com. 2. ECMO Centre Karolinska, Paediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden; Department of Paediatric Surgery, Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. 3. ECMO Centre Karolinska, Paediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: The dawning of the extracorporeal membrane oxygenation (ECMO)-2 era, with the potential of decentralizing ECMO treatment, has stressed the need for research into the safety of ECMO transportations. The aim of this study was to (1) provide a comprehensive summary of transport arrangements and complications at a high-volume ECMO center, (2) determine predictors of severe complications occurring during transport, and (3) determine transport-related predictors of mortality. METHODS: This was a retrospective population-based observational cohort study of all interhospital ECMO transports performed by the Karolinska University Hospital between 1996 and 2017. Medical records, clinical notes, and original transport protocols were collected and reviewed. RESULTS: A total of 908 ECMO transports were performed. Neonatal and pediatric patients were more likely to be subjected to international transport, air transport, and longer transport distances and transport times. A severe complication occurred in 20% of transports and was significantly associated with venoarterial ECMO (p = 0.04) and fixed-wing transport (p = 0.01). Severe transport complications were not associated with increased mortality. Two patients passed away during transportation. CONCLUSIONS: Severe complications during ECMO transportation recurrently occurred but did not affect mortality. We conclude that interhospital ECMO transportation is safe, when conducted by an experienced center, and patients should be transported for treatment at a high-volume ECMO center in accordance with the hub-and-spoke model whenever feasible.
BACKGROUND: The dawning of the extracorporeal membrane oxygenation (ECMO)-2 era, with the potential of decentralizing ECMO treatment, has stressed the need for research into the safety of ECMO transportations. The aim of this study was to (1) provide a comprehensive summary of transport arrangements and complications at a high-volume ECMO center, (2) determine predictors of severe complications occurring during transport, and (3) determine transport-related predictors of mortality. METHODS: This was a retrospective population-based observational cohort study of all interhospital ECMO transports performed by the Karolinska University Hospital between 1996 and 2017. Medical records, clinical notes, and original transport protocols were collected and reviewed. RESULTS: A total of 908 ECMO transports were performed. Neonatal and pediatric patients were more likely to be subjected to international transport, air transport, and longer transport distances and transport times. A severe complication occurred in 20% of transports and was significantly associated with venoarterial ECMO (p = 0.04) and fixed-wing transport (p = 0.01). Severe transport complications were not associated with increased mortality. Two patients passed away during transportation. CONCLUSIONS: Severe complications during ECMO transportation recurrently occurred but did not affect mortality. We conclude that interhospital ECMO transportation is safe, when conducted by an experienced center, and patients should be transported for treatment at a high-volume ECMO center in accordance with the hub-and-spoke model whenever feasible.
Authors: Yang-Chao Zhao; Xi Zhao; Guo-Wei Fu; Ming-Jun Huang; Hui Zhao; Zhen-Qing Wang; Xing-Xing Li; Jun Li Journal: Front Med (Lausanne) Date: 2022-06-13
Authors: Riccardo Iacobelli; Alexander Fletcher-Sandersjöö; Caroline Lindblad; Boris Keselman; Eric Peter Thelin; Lars Mikael Broman Journal: Sci Rep Date: 2021-02-15 Impact factor: 4.379
Authors: Mateusz Puslecki; Konrad Baumgart; Marcin Ligowski; Marek Dabrowski; Sebastian Stefaniak; Malgorzata Ladzinska; Ewa Goszczynska; Pawel Marcinkowski; Anna Olasinska-Wisniewska; Tomasz Klosiewicz; Aleksander Pawlak; Marcin Zielinski; Lukasz Puslecki; Roland Podlewski; Lukasz Szarpak; Marek Jemielity; Bartlomiej Perek Journal: Emerg Med Int Date: 2021-02-22 Impact factor: 1.112
Authors: Jeffrey Javidfar; Ahmed Labib; Gabrielle Ragazzo; Ethan Kurtzman; Maria Callahan; Silver Heinsar; Vadim Gudzenko; Peter Barrett; José Binongo; Jane Wenjing Wei; John Fraser; Jacky Y Suen; Gianluigi Li Bassi; Giles Peek Journal: ASAIO J Date: 2022-02-01 Impact factor: 2.872
Authors: Alexander Assmann; Andreas Beckmann; Christof Schmid; Karl Werdan; Guido Michels; Oliver Miera; Florian Schmidt; Stefan Klotz; Christoph Starck; Kevin Pilarczyk; Ardawan Rastan; Marion Burckhardt; Monika Nothacker; Ralf Muellenbach; York Zausig; Nils Haake; Heinrich Groesdonk; Markus Ferrari; Michael Buerke; Marcus Hennersdorf; Mark Rosenberg; Thomas Schaible; Harald Köditz; Stefan Kluge; Uwe Janssens; Matthias Lubnow; Andreas Flemmer; Susanne Herber-Jonat; Lucas Wessel; Dirk Buchwald; Sven Maier; Lars Krüger; Andreas Fründ; Rolf Jaksties; Stefan Fischer; Karsten Wiebe; Christiane S Hartog; Omer Dzemali; Daniel Zimpfer; Elfriede Ruttmann-Ulmer; Christian Schlensak; Malte Kelm; Stephan Ensminger; Udo Boeken Journal: ESC Heart Fail Date: 2021-11-22